Literature DB >> 19464633

Technological advances in radiation oncology for central nervous system tumors.

Shin-ei Noda1, Tim Lautenschlaeger, Michael R Siedow, Disha R Patel, Areej El-Jawahri, Yoshiyuki Suzuki, Jay S Loeffler, Marc R Bussiere, Arnab Chakravarti.   

Abstract

Advances in computer software technology have led to enormous progress that has enabled increasing levels of complexity to be incorporated into radiotherapy treatment planning systems. Because of these changes, the delivery of radiotherapy evolved from therapy designed primarily on plain 2-dimensional X-ray images and hand calculations to therapy based on 3-dimensional images incorporating increasingly complex computer algorithms in the planning process. In addition, challenges in treatment planning and radiation delivery, such as problems with setup error and organ movement, have begun to be systematically addressed, ushering in an era of so-called 4-dimensional radiotherapy. This review article discusses how these advances have changed the way in which many common neoplasms of the central nervous system are being treated at present.

Entities:  

Mesh:

Year:  2009        PMID: 19464633     DOI: 10.1016/j.semradonc.2009.02.006

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  4 in total

1.  Intracavitary moderator balloon combined with (252)Cf brachytherapy and boron neutron capture therapy, improving dosimetry in brain tumour and infiltrations.

Authors:  S F Brandão; T P R Campos
Journal:  Br J Radiol       Date:  2015-04-30       Impact factor: 3.039

2.  CyberKnife enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures.

Authors:  Eric Oermann; Brian T Collins; Kelly T Erickson; Xia Yu; Sue Lei; Simeng Suy; Heather N Hanscom; Joy Kim; Hyeon U Park; Andrew Eldabh; Christopher Kalhorn; Kevin McGrail; Deepa Subramaniam; Walter C Jean; Sean P Collins
Journal:  J Hematol Oncol       Date:  2010-06-09       Impact factor: 17.388

3.  Čerenkov excited fluorescence tomography using external beam radiation.

Authors:  Jennifer-Lynn Demers; Scott C Davis; Rongxiao Zhang; David J Gladstone; Brian W Pogue
Journal:  Opt Lett       Date:  2013-04-15       Impact factor: 3.776

4.  MEK-ERK-dependent multiple caspase activation by mitochondrial proapoptotic Bcl-2 family proteins is essential for heavy ion irradiation-induced glioma cell death.

Authors:  A Tomiyama; K Tachibana; K Suzuki; S Seino; J Sunayama; K-i Matsuda; A Sato; Y Matsumoto; T Nomiya; K Nemoto; H Yamashita; T Kayama; K Ando; C Kitanaka
Journal:  Cell Death Dis       Date:  2010-07-29       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.